Novartis (NYSE: NVS) reported Q1 EPS of $1.71, $0.18 better than the analyst estimate of $1.53. Revenue for the quarter came in at $12.95 billion versus the consensus estimate of $12.75 billion.

For earnings history and earnings-related data on Novartis (NVS) click here.